Medical device maker Stryker said it has reached a deal to acquire Inari Medical for $80 per share in cash, representing an ...

Inari Medical (NARI) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

Stryker said its planned acquisition of Inari Medical would strengthen its position in the peripheral vascular market.

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Inari Medical ( (NARI) ) has provided an update.

Why the splash? Inari's game-changing clot-removal devices for deep vein thrombosis (DVT) and pulmonary embolism (PE) are a ...

Shares of Inari Medical (TASE: PMCN) (NASDAQ:NARI) soared today after Stryker (NYSE:NYSE: SYK), a prominent player in the medical technology field, announced a de ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...